Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin)

Advances in Contraception

Volumn 12, Issue 2, 1996, Pages 101-109

  Csemiczky, G ^a   Alvendal, C ^a   Landgren, B M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLLITROPIN; OFLOXACIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; OVARY FOLLICLE; OVULATION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK;

ADULT; ANTI-INFECTIVE AGENTS; COHORT STUDIES; CONTRACEPTIVES, ORAL, COMBINED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTRADIOL; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; OFLOXACIN; OVULATION; PROGESTERONE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0029736960     PISSN: 02674874     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01849631     Document Type: Article

References (17)

1. Back DJ, Orme MLE. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990;18:472-84.
2. Lesher GY, Froelich ED, Gruet MD, Bailey JH, Brundage RP 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem. 1962;5:1063-8.
3. Neu HC. Quinolone antimicrobial agents. Ann Rev Med. 1992;43:465-86.
4. Leroy A, Borsa F, Humbert G, Bernedet P, Fillaske JP. The pharmacokinetics of ofloxacin in healthy adult male volunteers. Eur J Clin Pharmacol. 1987;31:629-30.
5. Method Manual WHO, Special Programme of Research, Development and Research Training in Human Reproduction. 1986.
6. Aso T, Guerrero R, Cekan Z, Diczfalusy E. A rapid 5-hour radioimmunoassay of progesterone and estradiol in human plasma. Clin Endocrinol. 1975;4:173-82.
7. Back DJ, Grimmer SFM, Orme MLE, Proudlove C, Mann RD, Breckenridge AM. Evaluation of Committee on Safety of Medicines yellow card report on oral contraceptive - drug interaction with anticonvulsants and antibiotics. Br J Clin Pharmacol. 1988;25:527-32.
8. Back DJ, Breckenridge AM, MacIver M et al. The effects of ampicillin on oral contraceptive steroids in women. Br J Clin Pharmacol. 1982;14:43-8.
9. Grimmer SFM, Allen WL, Back DJ, Breckenridge AM, Orme M, Tija J. The effect of cotrimoxazole on oral contraceptive steroids in women. Contraception. 1983;28:53-9.
10. Friedman I, Huneke AL, Kim MH, Powell J. The effect of ampicillin on oral contraceptive effectiveness. Obstet Gynecol. 1980;55:33-7.
11. Joshi JV, Joshi UM, Sankholi GM et al. A study of interaction of low-dose combination oral contraceptive with ampicillin and mentronidazole. Contraception. 1980;22:643-52.
12. Back DJ, Tija J, Martin C et al. The lack of interaction between temafloxacin and combined oral contraceptive steroids. Contraception. 1992;43:317-23.
13. Wang E, Shi S, Cekan S-Z, Landgren B-M, Diczfalusy E. Hormonal consequences of 'missing the pill'. Contraception. 1982;26:545-66.
14. Landgren B-M, Diczfalusy E. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. Contraception. 1984;29:437-46.
15. Hamilton CJCM, Hoogland Henk J. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. Am J Obstet Gynecol. 1989;161:1159-62.
16. Killick SR. Ovarian follicles during oral contraceptive cycles: their potential for ovulation. Fertil Steril. 1989;52:580-82.
17. Van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception. 1990;42:597-609.